FDA Inspection
Sabeen Najam, MDFDA Inspection 1134831 - Sabeen Najam, MD - January 20, 2021
Record Details
This FDA Inspection record concerns Sabeen Najam, MD, with an inspection on January 20, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sabeen Najam, MD
- Inspection Date
- January 20, 2021
- Product Type
- Drugs
View Company Profile
ID · 1d82bffb-9a07-4991-a976-165936382264
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1134831
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.